Real-Time PCR, Digital PCR And End-Point PCR Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What combination of drivers is leading to accelerated growth in the real-time pcr, digital pcr and end-point pcr market?
The rise in infectious diseases is predicted to spur the expansion of the real-time PCR, digital PCR, and end-point PCR markets. These diseases arise from the supposed attack and flourishing of harmful organisms such as bacteria, viruses, fungi, and parasites. Techniques such as real-time PCR, digital PCR, and end-point PCR are implemented to measure specific pathogens or their genetic components, observe the advancement of the disease, and quickly determine infections like HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, the UNAIDS data from July 2023 declared that there was an increase of 3.17% in the global population living with HIV from 37.7 million in 2020 to 39 million in 2022. In addition, about 1.3 million new HIV infections were recorded in 2022. Moreover, as per the data from the Centers for Disease Control and Prevention in March 2023, tuberculosis cases in the US escalated to 8,300 in 2022 from 7,874 cases in 2021. Consequently, the surge in infectious diseases will catalyze the growth of the cephalosporin market. The growth of the real-time PCR, digital PCR, and end-point PCR markets can also be attributed to the rise in chronic diseases. These health issues are characterized by a long duration and often a slow progression. Healthcare providers use real-time PCR to promptly and accurately diagnose these diseases by identifying specific DNA or RNA markers linked to chronic conditions like cancer, diabetes, and viral infections. According to the World Health Organization's September 2022 data, non-communicable or chronic diseases account for 74% of deaths worldwide every year, which is equivalent to 41 million deaths. The figure includes 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the upsurge in chronic diseases is propelling the growth of the real-time PCR, digital PCR, and end-point PCR market.

Get Your Real-Time PCR, Digital PCR And End-Point PCR Market Report Here:
https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report

What is the projected compound annual growth rate (CAGR) of the real-time pcr, digital pcr and end-point pcr market from 2025 to 2034, and what factors influence it?
In recent years, the size of the real-time PCR, digital PCR, and end-point PCR market has seen robust growth. It is expected to expand from a worth of $38.37 billion in 2024 to reach $41.88 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.2%. The notable growth in the past period has been driven by a number of factors including the standardization of PCR protocols, its usage in personalized medicine, its invaluable contribution to drug discovery and development, as well as its adoption in the fields of forensic and paternity testing.

In the near future, the market size for real-time pcr, digital pcr, and end-point pcr is projected to witness substantial growth. By the year 2029, it is anticipated that it will expand to $60.91 billion, with an impressive compound annual growth rate (CAGR) of 9.8%. The growth in this period is predicted to be driven by the expansion of molecular diagnostics, a surge in infectious disease testing, increasing demand for genetic testing, market penetration in research and forensics, and the development of swift point-of-care PCR solutions. Notable trends in this period include the evolution of digital assays, advancements in multiplex PCR, a movement towards digital PCR technology, automation, high-throughput systems, and miniaturization of PCR platforms.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp

How are the latest trends influencing the growth of the real-time pcr, digital pcr and end-point pcr market?
Leading enterprises in the real-time PCR, digital PCR, and endpoint PCR markets are harnessing breakthrough technologies such as digital polymerase chain reaction (dPCR) technology to revolutionize the understanding of patient's cancer, genetic ailment, or infection. Digital polymerase chain reaction (dPCR) technology represents a significant enhancement of traditional PCR techniques, enabling the direct quantification and clonal amplification of DNA, cDNA, or RNA. For example, in August 2022, Roche Diagnostics, a US-based pharmaceutical and medical device producer, unveiled its cutting-edge digital PCR Digital LightCycler System meant for the timely detection and treatment of various genetic and chronic diseases. This system is engineered to automate workflow and control data, negating the necessity for additional computations, software, and processing units. A blend of three nano well plate arrangements, six superior optical channels, and 5x concentrated DNA and RNA master mixes ensure heightened sensitivity and precision. The Digital LightCycler System fortifies Roche's diagnostic platform lineup, offering performance-oriented technology, clinical applications, adaptability, and workflow efficiency.

What are the major segments of the real-time pcr, digital pcr and end-point pcr market and their role in driving growth?
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented -

1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations

Subsegments:
1) By Instruments: Real-Time PCR Systems, Digital PCR Systems, End-Point PCR Systems
2) By Consumables And Reagents: PCR Plates And Tubes, Primers And Probes, PCR Master Mix, DNA Polymerases And Nucleotides
3) By Software And Services: Analysis Software, Data Management Software, Calibration And Maintenance Services, Training And Support Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13296

What regions are at the forefront of real-time pcr, digital pcr and end-point pcr market expansion?
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time PCR, digital PCR and end-point PCR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the key firms paving the way for growth in the real-time pcr, digital pcr and end-point pcr market?
Major companies operating in the real-time PCR, digital PCR and end-point PCR market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG, Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13296&type=smp

What Is Covered In The Real-Time PCR, Digital PCR And End-Point PCR Global Market Report?

•Market Size Forecast: Examine the real-time pcr, digital pcr and end-point pcr market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the real-time pcr, digital pcr and end-point pcr market for a structured understanding.
•Key Players Overview: Analyze major players in the real-time pcr, digital pcr and end-point pcr market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the real-time pcr, digital pcr and end-point pcr market.
•Segment Contributions: Evaluate how different segments drive overall growth in the real-time pcr, digital pcr and end-point pcr market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the real-time pcr, digital pcr and end-point pcr market.
•Industry Challenges: Identify potential risks and obstacles affecting the real-time pcr, digital pcr and end-point pcr market.
•Competitive Landscape: Review strategic developments in the real-time pcr, digital pcr and end-point pcr market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.